Vaccination in Individuals with Multiple Sclerosis – Part II Multipl Skleroz Tanılı Bireylerde Aşılama – Bölüm II

Creative Commons License

Piri Çınar B., Tuncer A., BİLGE N., BÜNÜL S. D., Gözübatık-çelik R. G., Çiftçi E. D., ...Daha Fazla

Turk Noroloji Dergisi, cilt.29, sa.2, ss.85-94, 2023 (ESCI) identifier identifier identifier

  • Yayın Türü: Makale / Derleme
  • Cilt numarası: 29 Sayı: 2
  • Basım Tarihi: 2023
  • Doi Numarası: 10.4274/tnd.2023.16984
  • Dergi Adı: Turk Noroloji Dergisi
  • Derginin Tarandığı İndeksler: Emerging Sources Citation Index (ESCI), Scopus, Academic Search Premier, CINAHL, EMBASE, Directory of Open Access Journals, TR DİZİN (ULAKBİM)
  • Sayfa Sayıları: ss.85-94
  • Anahtar Kelimeler: Multiple sclerosis, safety, vaccination
  • Erciyes Üniversitesi Adresli: Evet

Özet

Multiple sclerosis (MS) is an autoimmune and demyelinating disease of the central nervous system. It is a chronic disease, and in the evaluation of all other health and vital processes, decisions about vaccination should be made considering the disease process and the medications used by the patient. Since vaccination can be performed at any stage of life, immune system activity should be reviewed in patients with MS except where it is characteristic of the vaccine. In this review, the applications of different vaccines in patients with MS are discussed in two separate sections (part 1 was published in the previous issue).